Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine

Journal of the American Society for Mass Spectrometry

Volumn 26, Issue 6, 2015, Pages 853-861

  Carreira, Ricardo J ^a   Shyti, Reinald ^a   Balluff, Benjamin ^a   Abdelmoula, Walid M ^a   Van Heiningen, Sandra H ^a   Van Zeijl, Rene J ^a   Dijkstra, Jouke ^a   Ferrari, Michel D ^a   Tolner, Else A ^a   McDonnell, Liam A ^a,b   Van Den Maagdenberg, Arn M J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Fondazione Pisana per la Scienza ONLUS   (Italy)

Author keywords

Cortical spreading depression; Familial hemiplegic migraine; MALDI; Mass spectrometry imaging; Preclinical studies

Indexed keywords

BRAIN; ELECTROPHYSIOLOGY; MASS SPECTROMETRY; SPECTROMETRY;

CORTICAL SPREADING DEPRESSION; FAMILIAL HEMIPLEGIC MIGRAINES; MALDI; MASS-SPECTROMETRY IMAGING; PRECLINICAL STUDIES;

MAMMALS;

PEPTIDE; CALCIUM CHANNEL N TYPE; VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FAMILIAL HEMIPLEGIC MIGRAINE; GENOTYPE; HEMISPHERE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIGRAINE; MISSENSE MUTATION; MOUSE; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; SPREADING CORTICAL DEPRESSION; STUDENT T TEST; THALAMUS; TISSUE SECTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BRAIN; CEREBELLAR ATAXIA; DISEASE MODEL; FEMALE; GENETICS; HUMAN; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; BRAIN; CALCIUM CHANNELS, N-TYPE; CEREBELLAR ATAXIA; CORTICAL SPREADING DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE, TRANSGENIC; MIGRAINE DISORDERS; MUTATION, MISSENSE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84929091197     PISSN: 10440305     EISSN: 18791123     Source Type: Journal    
DOI: 10.1007/s13361-015-1136-8     Document Type: Article

References (61)

1. Caprioli, R.M., Farmer, T.B., Gile, J.: Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69, 4751-4760 (1997)
2. McDonnell, L.A., Heeren, R.M., Andrén, P.E., Stoeckli, M., Corthals, G.L.: Going forward: increasing the accessibility of imaging mass spectrometry. J. Proteome. 75, 5113-5121 (2012)
3. Norris, J.L., Caprioli, R.M.: Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem. Rev. 113, 2309-2342 (2013)
4. McDonnell, L.A., Heeren, R.M.A.: Imaging mass spectrometry. Mass Spectrom. Rev. 26, 606-643 (2007)
5. McDonnell, L.A., Corthals, G.L., Willems, S.M., van Remoortere, A., van Zeijl, R.J., Deelder, A.M.: Peptide and protein imaging mass spectrometry in cancer research. J. Proteome. 73, 1921-1944 (2010)
6. Balluff, B., Schöne, C., Höfler, H., Walch, A.: MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications. Histochem. Cell Biol. 136, 227-244 (2011)
7. Kaspar, S., Peukert, M., Svatos, A., Matros, A., Mock, H.-P.P.: MALDI-imaging mass spectrometry - an emerging technique in plant biology. Proteomics 11, 1840-1850 (2011)
8. Hanrieder, J., Phan, N.T.N., Kurczy, M.E., Ewing, A.G.: Imaging mass spectrometry in neuroscience. ACS Chem. Neurosci. 4, 666-679 (2013)
9. Shariatgorji, M., Svenningsson, P., Andrén, P.E.: Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology 39, 34-49 (2014)
10. Hafezparast, M., Ahmad-Annuar, A., Wood, N.W., Tabrizi, S.J., Fisher, E.M.: Mouse models for neurological disease. Lancet Neurol. 1, 215-224 (2002)
11. Sugiura, Y., Taguchi, R., Setou, M.: Visualization of spatiotemporal energy dynamics of hippocampal neurons by mass spectrometry during a kainate-induced seizure. PLoS One 6, e17952 (2011)
12. Miura, D., Fujimura, Y., Yamato, M., Hyodo, F., Utsumi, H., Tachibana, H., Wariishi, H.: Ultrahighly sensitive in situ metabolomic imaging for visualizing spatiotemporal metabolic behaviors. Anal. Chem. 82, 9789-9796 (2010)
13. Stoeckli, M., Knochenmuss, R., McCombie, G., Mueller, D., Rohner, T., Staab, D., Wiederhold, K.-H.H.: MALDI MS imaging of amyloid. Methods Enzymol. 412, 94-106 (2006)
14. Rohner, T.C., Staab, D., Stoeckli, M.: MALDI mass spectrometric imaging of biological tissue sections. Mech. Ageing Dev. 126, 177-185 (2005)
15. Pierson, J., Norris, J.L., Aerni, H.R., Svenningsson, P., Caprioli, R.M., Andrén, P.E.: Molecular profiling of experimental parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by maldi Mass Spectrometry. J. Proteome Res. 3, 289-295 (2004)
16. Nilsson, A., Sköld, K., Sjögren, B., Svensson, M., Pierson, J., Zhang, X., Caprioli, R.M., Buijs, J., Persson, B., Svenningsson, P., Andrén, P.E.: Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. J. Proteome Res. 6, 3952-3961 (2007)
17. Ljungdahl, A., Hanrieder, J., Fälth, M., Bergquist, J., Andersson, M.: Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease. PloS one 6, e25653 (2011)
18. Hager, R., Lu, L., Rosen, G.D., Williams, R.W.: Genetic architecture supports mosaic brain evolution and independent brain-body size regulation. Nat. Commun. 3, 1079 (2012)
19. Abdelmoula, W.M., Carreira, R.J., Shyti, R., Balluff, B., van Zeijl, R.J., Tolner, E.A., Lelieveldt, B.F., van den Maagdenberg, A.M., McDonnell, L.A., Dijkstra, J.: Automatic registration of mass spectrometry imaging data sets to the Allen brain atlas. Anal. Chem. 86, 3947-3954 (2014)
20. ICHD: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(Suppl 1), 9-160 (2004)
21. Goadsby, P.J., Lipton, R.B., Ferrari, M.D.: Migraine-current understanding and treatment. N. Engl. J. Med. 346, 257-270 (2002)
22. Hadjikhani, N., Sanchez Del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., Kwong, K.K., Cutrer, F.M., Rosen, B.R., Tootell, R.B., Sorensen, A.G., Moskowitz, M.A.: Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. U. S. A. 98, 4687-4692 (2001)
23. Lauritzen, M.: Pathophysiology of the migraine aura. The spreading depression theory. Brain 117(Pt 1), 199-210 (1994)
24. Pietrobon, D., Moskowitz, M.A.: Pathophysiology of migraine. Annu. Rev. Physiol. 75, 365-391 (2013)
25. Selman, W.R., Lust, W.D., Pundik, S., Zhou, Y.N., Ratcheson, R.A.: Compromised metabolic recovery following spontaneous spreading depression in the penumbra. Brain Res. 999, 167-174 (2004)
26. Jones, E.A., Shyti, R., van Zeijl, R.J., van Heiningen, S.H., Ferrari, M.D., Deelder, A.M., Tolner, E.A., van den Maagdenberg, A.M., McDonnell, L.A.: Imaging mass spectrometry to visualize biomolecule distributions in mouse brain tissue following hemispheric cortical spreading depression. J. Proteome. 75, 5027-5035 (2012)
27. van den Maagdenberg, A.M., Pietrobon, D., Pizzorusso, T., Kaja, S., Broos, L.A., Cesetti, T., van de Ven, R.C., Tottene, A., van der Kaa, J., Plomp, J.J., Frants, R.R., Ferrari, M.D.: A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701-710 (2004)
28. Ferrari, M.D., Klever, R.R., Terwindt, G.M., Ayata, C., van den Maagdenberg, A.M.: Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 14, 65-80 (2015)
29. Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., van Eijk, R., Oefner, P.J., Hoffman, S.M., Lamerdin, J.E., Mohrenweiser, H.W., Bulman, D.E., Ferrari, M., Haan, J., Lindhout, D., van Ommen, G.J., Hofker, M.H., Ferrari, M.D., Frants, R.R.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543-552 (1996)
30. Eikermann-Haerter, K., Dilekoz, E., Kudo, C., Savitz, S.I., Waeber, C., Baum, M.J., Ferrari, M.D., van den Maagdenberg, A.M., Moskowitz, M.A., Ayata, C.: Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J. Clin. Invest. 119, 99-109 (2009)
31. Tottene, A., Conti, R., Fabbro, A., Vecchia, D., Shapovalova, M., Santello, M., van den Maagdenberg, A.M., Ferrari, M.D., Pietrobon, D.: Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knock-in migraine mice. Neuron 61, 762-773 (2009)
32. Eikermann-Haerter, K., Yuzawa, I., Qin, T., Wang, Y., Baek, K., Kim, Y.R., Hoffmann, U., Dilekoz, E., Waeber, C., Ferrari, M.D., van den Maagdenberg, A.M.J.M., Moskowitz, M.A., Ayata, C.: Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J. Neurosci. 31, 5755-5763 (2011)
33. McDonnell, L.A., van Remoortere, A., de Velde, N., van Zeijl, R.J., Deelder, A.M.: Imaging mass spectrometry data reduction: automated feature identification and extraction. J. Am. Soc. Mass Spectrom. 21, 1969-1978 (2010)
34. Veselkov, K.A., Mirnezami, R., Strittmatter, N., Goldin, R.D., Kinross, J., Speller, A.V., Abramov, T., Jones, E.A., Darzi, A., Holmes, E., Nicholson, J.K., Takats, Z.: Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 111, 1216-1221 (2014)
35. Keenan, M.R., Kotula, P.G.: Accounting for Poisson noise in the multivariate analysis of ToF-SIMS spectrum images. Surf. Interface Anal. 36, 203-212 (2004)
36. Hattori, K., Kajimura, M., Hishiki, T., Nakanishi, T., Kubo, A., Nagahata, Y., Ohmura, M., Yachie-Kinoshita, A., Matsuura, T., Morikawa, T., Nakamura, T., Setou, M., Suematsu, M.: Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry. Antioxid. Redox Signal. 13, 1157-1167 (2010)
37. Sugiura, Y., Honda, K., Kajimura, M., Suematsu, M.: Visualization and quantification of cerebral metabolic fluxes of glucose in awake mice. Proteomics 14, 829-838 (2014)
38. Blatherwick, E.Q., Svensson, C.I., Frenguelli, B.G., Scrivens, J.H.: Localization of adenine nucleotides in heat-stabilised mouse brains using ion mobility enabled MALDI imaging. Int. J. Mass Spectrom. 345, 19-27 (2013)
39. Somjen, G.G.: Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81, 1065-1096 (2001)
40. Poté, N., Alexandrov, T., Le Faouder, J., Laouirem, S., Léger, T., Mebarki, M., Belghiti, J., Camadro, J.-M.M., Bedossa, P., Paradis, V.: Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas. Hepatology 58, 983-994 (2013)
41. Passaro, D., Rana, G., Piscopo, M., Viggiano, E., De Luca, B., Fucci, L.: Epigenetic chromatin modifications in the cortical spreading depression. Brain Res. 1329, 1-9 (2010)
42. Rana, G., Donizetti, A., Virelli, G., Piscopo, M., Viggiano, E., De Luca, B., Fucci, L.: Cortical spreading depression differentially affects lysine methylation of H3 histone at neuroprotective genes and retrotransposon sequences. Brain Res. 1467, 113-119 (2012)
43. Konsoula, Z., Barile, F. A.: Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J. Pharmacol. Toxicol. Methods 66, 215-220 (2012)
44. Tozzi, A., de Iure, A., Di Filippo, M., Costa, C., Caproni, S., Pisani, A., Bonsi, P., Picconi, B., Cupini, L.M., Materazzi, S., Geppetti, P., Sarchielli, P., Calabresi, P.: Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc. Natl. Acad. Sci. U. S. A. 109, 18985-18990 (2012)
45. Colonna, D.M., Meng, W., Deal, D.D., Busija, D.W.: Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am. J. Physiol. 266, H1095-H1102 (1994)
46. Ho, T.W., Edvinsson, L., Goadsby, P.J.: CGRP and its receptors provide new insights into migraine pathophysiology. Nat. Rev. Neurol. 6, 573-582 (2010)
47. Raddant, A.C., Russo, A.F.: Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev. Mol. Med. 13, e36 (2011)
48. Wahl, M., Schilling, L., Parsons, A.A., Kaumann, A.: Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 637, 204-210 (1994)
49. Bolay, H., Reuter, U., Dunn, A.K., Huang, Z., Boas, D.A., Moskowitz, M.A.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8, 136-142 (2002)
50. Fusayasu, E., Kowa, H., Takeshima, T., Nakaso, K., Nakashima, K.: Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128, 209-214 (2007)
51. Goadsby, P.J., Edvinsson, L., Ekman, R.: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28, 183-187 (1990)
52. Gallai, V., Sarchielli, P., Floridi, A., Franceschini, M., Codini, M., Glioti, G., Trequattrini, A., Palumbo, R.: Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15, 384-390 (1995)
53. Fabricius, M., Jensen, L.H., Lauritzen, M.: Microdialysis of interstitial amino acids during spreading depression and anoxic depolarization in rat neocortex. Brain Res. 612, 61-69 (1993)
54. Ferrari, M.D., Odink, J., Bos, K.D., Malessy, M.J., Bruyn, G.W.: Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 40, 1582-1586 (1990)
55. Martinez, F., Castillo, J., Rodriguez, J.R., Leira, R., Noya, M.: Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13, 89-93 (1993)
56. Peres, M.F., Zukerman, E., Senne Soares, C.A., Alonso, E.O., Santos, B.F., Faulhaber, M.H.: Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24, 735-739 (2004)
57. Andreou, A.P., Goadsby, P.J.: Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin. Investig. Drugs 18, 789-803 (2009)
58. Van Harreveld, A.: Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. J. Neurochem. 3, 300-315 (1959)
59. Basarsky, T.A., Feighan, D., MacVicar, B.A.: Glutamate release through volume-activated channels during spreading depression. J. Neurosci. 19, 6439-6445 (1999)
60. Klychnikov, O.I., Li, K.W., Sidorov, I.A., Loos, M., Spijker, S., Broos, L.A., Frants, R.R., Ferrari, M.D., Mayboroda, O.A., Deelder, A.M., Smit, A.B., van den Maagdenberg, A.M.: Quantitative cortical synapse proteomics of a transgenic migraine mouse model with mutated Ca(V)2.1 calcium channels. Proteomics 10, 2531-2535 (2010)
61. Eikermann-Haerter, K., Lee, J.H., Yuzawa, I., Liu, C.H., Zhou, Z., Shin, H.K., Zheng, Y., Qin, T., Kurth, T., Waeber, C., Ferrari, M.D., van den Maagdenberg, A.M., Moskowitz, M.A., Ayata, C.: Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 125, 335-345 (2012)